Simulations Plus (NASDAQ:SLP) Lowered to "Sell" Rating by StockNews.com

StockNews.com cut shares of Simulations Plus (NASDAQ:SLP - Free Report) from a hold rating to a sell rating in a report released on Monday morning.

SLP has been the topic of a number of other reports. William Blair restated an "outperform" rating on shares of Simulations Plus in a research report on Wednesday, January 8th. KeyCorp increased their price objective on shares of Simulations Plus from $35.00 to $37.00 and gave the company an "overweight" rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $50.00.

Simulations Plus Price Performance

Shares of SLP stock traded up $0.49 during mid-day trading on Monday, hitting $32.69. The company had a trading volume of 336,728 shares, compared to its average volume of 193,847. Simulations Plus has a 52-week low of $23.01 and a 52-week high of $51.22. The stock's 50 day moving average price is $28.55 and its 200-day moving average price is $30.09. The company has a market capitalization of $657.43 million, a P/E ratio of 81.73 and a beta of 1.13.

Simulations Plus (NASDAQ:SLP - Get Free Report) last issued its quarterly earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.25 by $0.06. Simulations Plus had a return on equity of 6.84% and a net margin of 10.97%. The firm had revenue of $22.43 million for the quarter, compared to analyst estimates of $21.93 million. During the same period in the previous year, the company posted $0.20 earnings per share. The business's revenue was up 22.5% on a year-over-year basis. On average, equities research analysts expect that Simulations Plus will post 1.09 earnings per share for the current year.

Insider Transactions at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $33.91, for a total transaction of $678,200.00. Following the sale, the director now directly owns 3,402,584 shares in the company, valued at $115,381,623.44. The trade was a 0.58 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 19.40% of the company's stock.

Institutional Trading of Simulations Plus

Several institutional investors have recently modified their holdings of SLP. State Street Corp boosted its stake in shares of Simulations Plus by 4.7% during the 3rd quarter. State Street Corp now owns 640,303 shares of the technology company's stock worth $20,503,000 after acquiring an additional 28,953 shares during the period. Barclays PLC raised its stake in Simulations Plus by 390.6% in the third quarter. Barclays PLC now owns 28,473 shares of the technology company's stock valued at $911,000 after purchasing an additional 22,669 shares in the last quarter. Geode Capital Management LLC grew its holdings in Simulations Plus by 4.4% in the 3rd quarter. Geode Capital Management LLC now owns 448,618 shares of the technology company's stock worth $14,367,000 after acquiring an additional 18,924 shares during the last quarter. Franklin Resources Inc. increased its stake in shares of Simulations Plus by 7.6% during the third quarter. Franklin Resources Inc. now owns 10,797 shares of the technology company's stock valued at $342,000 after purchasing an additional 766 shares in the last quarter. Finally, Principal Financial Group Inc. lifted its holdings in shares of Simulations Plus by 2.6% during the 3rd quarter. Principal Financial Group Inc. now owns 87,273 shares of the technology company's stock valued at $2,794,000 after buying an additional 2,226 shares during the period. Institutional investors and hedge funds own 78.08% of the company's stock.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.